Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Wed 29 Mar 2006, 16:32 Acucap - Specific issue of shares for cash and the
ACP
 ACP                                                                             
Acucap - Specific issue of shares for cash and the introduction of Thesele      
ACUCAP PROPERTIES LIMITED                                                       
(Incorporated in the Republic of South Africa)                                  
(Registration number 2001/021725/06)                                            
Share code: ACP  &  ISIN: ZAE000037651                                          
("Acucap")                                                                      
FURTHER INFORMATION REGARDING A SPECIFIC ISSUE OF SHARES FOR CASH AND THE       
INTRODUCTION OF THESELE GROUP (PROPRIETARY) LIMITED ("THESELE") AS AN EFFECTIVE 
10% BEE LINKED UNITHOLDER IN ACUCAP                                             
     1.   Introduction                                                          
          Linked unitholders are referred to the announcement dated 13 February 
2006 where they were advised that Acucap had entered into a memorandum
          of understanding with Thesele dated 10 February 2006 in terms of which
          Thesele will be introduced as an effective 10% BEE linked unitholder  
          in Acucap ("the transaction").                                        
The transaction was subject to the completion of final agreements, the
          obtaining of regulatory approvals, to the extent required and the     
          approval of Acucap linked unitholders in general meeting.             
     2.   Final subscription agreement                                          
Acucap has now entered into a final subscription agreement with CShell
          299 (Proprietary) Limited ("CShell"), a wholly-owned subsidiary of    
          Acucap, dated 24 March 2006 ("the subscription agreement") in terms of
          which Acucap will issue 7 620 994 new linked units for an amount of   
R182 903 856 ("the specific issue"). This represents a price of R24   
          per Acucap linked unit, being the 30 day volume weighted average      
          traded price of Acucap prior to 2 March 2006, the date on which the   
          subscription agreement, a severable and independent part of the       
proposed transaction, was finalised. The issue price reflects the full
          30 day volume weighted average traded price of Acucap, with no        
          discount, and has been adjusted from the previously announced level of
          R22.27 as a result of the significant increase in the traded price of 
Acucap linked units between 23 December 2005 and 2 March 2006.        
          The subscription value of the specific issue will still be settled by 
          Nedbank Limited ("the loan"), with the necessary security being       
          provided by Acucap and its wholly owned subsidiaries. Acucap will not 
be encumbering any of its assets as part of the transaction and there 
          will therefore be no operational impact of the transaction on Acucap. 
          Furthermore the other financial covenants to be provided by Acucap are
          consistent with those which Acucap has provided to its lenders in the 
The subscription agreement is subject to the approval of Acucap linked
          unitholders in general meeting and the finalisation and acceptance of 
          the terms and conditions of the loan to be obtained by CShell and     
          security to be provided by Acucap to Nedbank Corporate Property       
Finance Division.                                                     
          Further details of the subscription agreement will be set out in the  
          circular to Acucap linked unitholders referred to in paragraph 5      
          below.                                                                
3    The proposed disposal agreement                                       
          This agreement is to be concluded between Acucap and Thesele upon the 
          successful conclusion of negotiations between the Acucap Board and    
          Thesele ("the disposal agreement"). It is contemplated that under the 
disposal agreement, Thesele will acquire all the shares in and claims 
          against CShell, based on CShell"s net asset value with its holding in 
          Acucap valued at R24 per Acucap linked unit at the time of the        
          disposal ("the disposal"). The disposal will take place no later than 
12 May 2006 or such later date as the Acucap Board and Thesele may    
          agree upon. Further details of the proposed disposal agreement will be
          set out in the circular to Acucap linked unitholders referred to in   
          paragraph 5 below.                                                    
The pricing of the disposal agreement will reflect the change in      
          pricing of the subscription agreement, referred to in 2 above.        
     4    Revised financial effects of the specific issue and the disposal      
          Further to the specific issue and the disposal now taking place at R24
per linked unit, the revised effects of the specific issue and the    
          disposal are set out below.                                           
          The unaudited pro forma financial effects of the specific issue and   
          the disposal on Acucap"s earnings per share ("EPS"), headline earnings
per linked unit ("HEPS"), net asset value ("NAV") and tangible net    
          asset value ("NTAV") per linked unit are set out below, based on the  
          assumption that the disposal is successfully concluded. This unaudited
          pro forma financial information has been prepared for illustrative    
purposes only and because of its nature may not give a fair reflection
          of Acucap"s financial position and results of operations, nor the     
          effect and impact of the specific issue and the disposal going        
          forward, and is the responsibility of Acucap"s directors              
Per Acucap share (cents) +        Before     After (2)        Change  
          Per Acucap linked unit (cents) *  (1)                         (%)     
          EPS +                             264.31     237.34 (3) &     (10.2)  
                                                       (4)                      
HEPS*                             90.24      91.92 (3) &      1.9     
                                                       (4)                      
          Distribution*                     79.03      81.84 (3) &      3.6     
                                                       (4)                      
NAV & NTAV*                       17.63      18.28 (4)        3.7     
          Number of shares/linked units     67 059     74 681                   
          for EPS and HEPS purposes ("000)                                      
          Number of linked units for NAV    67 378     75 000                   
and NTAV ("000)                                                       
          Notes:                                                                
          1    Based on the unaudited published results for the six months ended
               30 September 2005. As at the date of this announcement, 68 588   
953 Acucap linked units are in issue.                            
          2    Based on the assumption that the specific issue took place on 1  
               April 2005 for income statement purposes and 30 September 2005   
               for balance sheet purposes. Further to this, it has been assumed 
that the disposal has been successfully concluded at CShell"s net
               asset value with its holding in Acucap valued at R24 per Acucap  
               linked unit, which does not have a material effect on Acucap"s   
               EPS, HEPS, distribution, NAV and NTAV. If the disposal is not    
successfully concluded, the specific issue would not have any    
               effect on Acucap"s EPS, HEPS, distribution, NAV and NTAV.        
          3    After taking into account the reduction in borrowings in terms of
               the specific issue.                                              
4    After taking into account the effect of the 7 620 994 new Acucap 
               linked units issued in terms of the specific issue.              
     5.   Documentation                                                         
          A circular setting out further details of the subscription agreement  
and a proposed disposal agreement and the general meeting to obtain   
          linked unitholder approval for the specific issue and linked          
          unitholder authority for the Acucap Board to conclude the disposal of 
          CShell on terms and conditions that are acceptable to the Acucap Board
will be despatched to Acucap linked unitholders in due course.        
Cape Town                                                                       
29 March 2006                                                                   
Investment bank and joint sponsor                                               
Nedbank Capital                                                                 
Independent reporting accountants and lead sponsor                              
KPMG                                                                            
Attorneys                                                                       
Cliffe Dekker Inc.                                                              
Date: 29/03/2006 04:32:36 PM Produced by the JSE SENS Department                
                                                                                
                                                                                
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
[  Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData

Profile Mobile App Google Play Store Apple App Store


Follow us on: